Story perspectives

Massachusetts Halts Transgender Treatments for Minors Amid Controversy

2/21/2026

Summary

Story summary

Baystate Health in Massachusetts halted transgender hormone treatments for minors amid concerns about federal funding and scrutiny by the Trump administration, and will transfer affected patients to Transhealth, a nonprofit organization.
New York University Langone Health ended its transgender program for young people, facing criticism from patients and lawmakers.
The American Society of Plastic Surgeons now advises delaying gender-related surgeries until age 19, citing insufficient evidence for benefits.

1 of 1

Story summary

Baystate Health in Massachusetts halted transgender hormone treatments for minors amid concerns about federal funding and scrutiny by the Trump administration, and will transfer affected patients to Transhealth, a nonprofit organization.
New York University Langone Health ended its transgender program for young people, facing criticism from patients and lawmakers.
The American Society of Plastic Surgeons now advises delaying gender-related surgeries until age 19, citing insufficient evidence for benefits.